` ACL (Australian Clinical Labs Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

ACL
vs
S&P/ASX 300

Over the past 12 months, ACL has significantly outperformed S&P/ASX 300, delivering a return of 34% compared to the S&P/ASX 300's 5% growth.

Stocks Performance
ACL vs S&P/ASX 300

Loading
ACL
S&P/ASX 300
Add Stock

Performance Gap
ACL vs S&P/ASX 300

Loading
ACL
S&P/ASX 300
Difference

Performance By Year
ACL vs S&P/ASX 300

Loading
ACL
S&P/ASX 300
Add Stock

Competitors Performance
Australian Clinical Labs Ltd vs Peers

Australian Clinical Labs Ltd
Glance View

Market Cap
617.3m AUD
Industry
Health Care

Australian Clinical Labs Ltd. provides pathology services. The company is headquartered in Melbourne, Victoria and currently employs 2,794 full-time employees. The company went IPO on 2021-05-14. The firm is engaged in private hospital pathology businesses in regions of Western Australia, Victoria, South Australia and the Northern Territory. Its brands include Australian Clinical Labs, SunDoctors, Helix Pathology, Southern Sun, BeFunctional Labs and Gribbles Veterinary Pathology. The Australian Clinical Labs provides pathology in Australia, servicing clinicians, patients, hospitals, commercial clients and public organizations. The SunDoctors offers diagnosis and treatment of skin cancer. The Helix Pathology delivers specialized histopathology and cytology testing services. The Southern Sun is the skin cancer lab and the commercial lab in Australia. The BeFunctional Labs assists practitioners in the diagnosis, treatment and management of patients by providing functional pathology tests. The Gribbles Veterinary Pathology provides animal health professionals with pathology service.

ACL Intrinsic Value
5.34 AUD
Undervaluation 42%
Intrinsic Value
Price
Back to Top